Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor.
Chhajlani. V V; Xu. X X; Blauw. J J; Sudarshi. S S
Key Findings
- Asp184 is essential for melanotan‑I (NDP‑MSH) binding to MC1R
- Mutating Ser6, Glu269, or Thr272 reduces binding affinity
- Extracellular loops of MC1R contain key ligand‑binding sites
Practical Outcomes
- For DIY users, this means that the effectiveness of melanotan‑I depends on how well it can interact with these receptor spots. While the paper doesn’t give dosing tips, it hints that peptide tweaks targeting these residues could change potency, and that any variants that disrupt these sites may be less effective.
Summary
The study shows that certain parts of the skin‑color receptor (MC1R) are crucial for the peptide melanotan‑I to stick to it. Changing specific amino acids, especially Asp184, stops the peptide from binding, while other changes weaken the connection.
Abstract
To investigate whether residues in the extracellular domains of melanocortin 1 receptor (MC1R) are required for ligand binding, a number of mutants were constructed where charged residues were converted to alanine. The residues targeted for mutagenesis were Ser6, Glu102, Arg109, Asp184, Glu269, and Thr272. The mutant receptor DNAs were transiently expressed in COS-1 cells and their ability to bind [N1e4,D-Phe7]-alpha-MSH (NDP-MSH) was evaluated. Substitution of Asp184 by alanine completely abolished the binding of radiolabelled NDP-MSH as well as ACTH, even though the mutated receptor could be detected on cell surface using anti MC1R specific polyclonal antiserum. Mutations of Ser6, Glu269 and Thr272 resulted in a considerable loss of affinity for radiolabelled NDP-MSH as well as the ability of alpha-MSH to displace the bound radiolabelled NDP-MSH. The results demonstrate that the extracellular loops of human MC1R contain important ligand binding epitopes.
Study Information
pubmed
1996
1996-02-15T00:00:00.000Z
10.1006/bbrc.1996.0266